Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» isatuximab
isatuximab
Sanofi axes cancer combo, early next-gen diabetes drug
Fierce Biotech
Thu, 10/31/19 - 10:09 am
Sanofi
R&D
diabetes
cancer
isatuximab
Libtayo
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
Sat, 07/13/19 - 11:34 am
GSK
HIV
FDA
Merck
Keytruda
Sanofi
isatuximab
Roche
JNJ
FDA accepts BLA filing for Sanofi's rival to J&J's Darzalex
Fierce Biotech
Wed, 07/10/19 - 10:30 am
Sanofi
FDA
Darzalex
relapsed or refractory multiple myeloma
isatuximab
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
Endpoints
Sun, 06/2/19 - 01:18 pm
Sanofi
Multiple Myeloma
isatuximab
ASCO 2019
Sanofi's isatuximab meets survival endpoint for third-line multiple myeloma
BioCentury
Tue, 02/5/19 - 10:09 am
Sanofi
FDA
EMA
isatuximab
relapsed or refractory multiple myeloma
Multiple Myeloma
Sanofi beefs up cancer drug pipeline, paying cash hungry ImmunoGen $30M for full rights to oncology portfolio
Endpoints
Tue, 05/30/17 - 10:40 am
Sanofi
Immunogen
oncology
M&A
isatuximab
Multiple Myeloma